We have obtained a vaccinia virus recombinant which contains a complete cDNA copy of the 26S RNA of Sindbis virus within the thymidine kinase gene of the vaccinia virus genome. This recombinant constitutively transcribed the Sindbis sequences throughout the infectious cycle, reflecting the dual early-late vaccinia promoter used in this construction. The Sindbis-derived transcripts were translationally active, giving rise to both precursor and mature structural proteins of Sindbis virus, including the capsid protein (C), the precursor of glycoprotein E2 (PE2), and the two mature envelope glycoproteins (El and E2). These are the same products translated from the 26S mRNA during Sindbis infection, and thus these proteins were apparently cleaved, glycosylated, and transported in a manner analogous to that seen during authentic Sindbis infections. By using epitope-specific antibodies, it was possible to demonstrate that recombinant-derived proteins were incorporated into Sindbis virions during coinfections with monoclonal antibody-resistant Sindbis variants. These results suggest that all the information necessary to specify the proper biogenesis of Sindbis virus structural proteins resides within the 26S sequences and that vaccinia may provide an appropriate system for using DNA molecular genetic manipulations to unravel a variety of questions pertinent to RNA virus replication.
Vaccinia virus, a poxvirus (reviewed in reference 30) , has a number of advantages for use as a eucaryotic expression vector. These include the broad host range of the virus, which allows genetic information to be shuttled among a variety of species and cell types; the size of the vaccinia virion and its DNA genome, which accommodates large or multiple foreign inserts (or both) in an infectious virus (47) ; high-titered stocks of infectious recombinant virus that enable virtually 100% of a cell population to be synchronously infected and to express the foreign gene; the absence of splicing during RNA maturation and cytoplasmic localization of vaccinia gene expression (mediated largely by viral enzymes), that allows proper expression of foreign inserts lacking introns or proper transport signals; and finally, the fact that vaccinia is a relatively safe vaccine strain. By using in vivo marker rescue techniques (18, 32, 57) , these attributes have been used in several laboratories to construct a number of recombinants that express influenza hemagglutinin (33, 47) , hepatitis B surface antigen (35, 46) , herpesvirus thymidine kinase (25, 34) and glycoprotein D antigen (35) , the malaria circumsporozoite antigen (45) , the rabies virus glycoprotein (21) , and the vesicular stomatitis virus G and N proteins (27) . Such recombinants may prove useful in the prevention of a variety of human diseases (31, 35, 47) , but such applications await further research into vaccinia virus pathogenesis and possible vaccination side effects.
Here we report initial studies on the use of vaccinia as an expression vector to study the production of Sindbis virusspecific proteins and RNA transcripts derived from cloned cDNA. Sindbis virus is the prototype of the alphavirus genus of the family Togaviridae. Alphaviruses replicate in the cytoplasm and contain a single-stranded RNA genome with plus strand polarity (reviewed in reference 52). Two species of viral mRNA are found in Sindbis-infected cells: 49S RNA, structions are found below and in the legend to Fig. 1 . E. coli MC1061 (5) was modified by P1 transduction (from strain C600; tnJO, recA56) to tetracycline resistance and a UVsensitive phenotype (probably recA56) and used to propagate recombinant plasmids. DNA transfection and marker rescue. A 5-p.g portion of cesium chloride-purified pVV3S DNA was coprecipitated with 1 pug of wild-type vaccinia DNA (to facilitate marker rescue) and 15 p.g of carrier salmon sperm DNA by using the calcium phosphate technique (12) . The DNA precipitates were added to monolayers of LTK-cells (without bromodeoxyuridine selection) which had been infected with wildtype vaccinia at a multiplicity of 0.05 PFU per cell 3 h previously. After 4 h, the cells were washed with serum-free medium and shocked for 40 s with 15% glycerol in HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid)-buffered saline (pH 7.1) (24) to facilitate DNA uptake; normal medium was added, and the infected or transfected monolayers were incubated at 37°C for 72 h. The progeny virions from this initial marker rescue step were harvested and titrated. TK-virus, including potential recombinants, was amplified by low-multiplicity passage through LTKcells in the presence of 25 jig of bromodeoxyuridine per ml.
The TK-vaccinia virus present in the amplified crude stock was then screened for recombinants containing the Sindbisspecific insert of interest by using the nitrocellulose in situ plaque hybridization procedure described by Villarreal and Berg (56) . Recombinants of interest were subjected to at least two rounds of plaque purification until 100% of the plaques scored as positive with appropriate radioactive probes.
DNA analyses. To obtain vaccinia DNA, 100-mm dishes of BSC-40 cells were infected with vaccinia virus at a multiplicity of 10 PFU per cell for 24 h. The infected cells were harvested, suspended in 600 pl1 of phosphate-buffered saline (PBS), and freeze-thawed three times. The crude extract was adjusted to 0.5% Triton X-100, 35 mM ,B-mercaptoethanol, and 20 mM EDTA, transferred to a 1.5-ml microfuge tube, and centrifuged in a Tomy microfuge (model RC-15A) at 3,000 rpm and 25°C for 2.5 min to pellet the cell nuclei. The supernatant was transferred to a fresh tube and centrifuged at 15,000 rpm and 25°C for 10 min to pellet virus core particles. The pellet was suspended in 100 p.l of 10 (42) . The DNA bands were visualized by staining with 0.5 p.g of ethidium bromide per ml and photographed with a Polaroid MP-4 camera set-up. The DNA was then blotted onto nitrocellulose and hybridized with appropriate nick-translated probes (49) .
RNA analyses. BSC-40 cells were infected for 5 h in the presence of 100 p.g of cycloheximide to amplify early mRNA sequences. Total infected cell RNA was extracted and purified either by the cesium chloride-Sarkosyl method (11) or by isolation of total nucleic acids followed by digestion with DNase I (54 10 .8% discontinuous SDS-polyacrylamide gels (53) . The gels were then impregnated with 2, 5-diphenyloxazole (3) and exposed on Kodak XAR-5 film at -70°C. The antisera used in these experiments were generated in rabbits with purified Sindbis proteins (38 (36) . Immunoprecipitations were done essentially as previously described except that buffers lacked detergent (38) . Two microliters of mouse ascites fluid and 104 to 105 PFU of virus were used for each sample. Washed immunoprecipitates were suspended and quantitated by liquid scintillation counting, and the immunoprecipitation supernatants were assayed for infectivity.
RESULTS
Construction of the vaccinia-Sindbis structural region recombination plasmid. The plasmid pGS20 is a vaccinia virus insertion vector that has been used to construct a number of vaccinia recombinants (26, 48) . The construction of a modified insertion plasmid, pVV3, and the recombinant plasmid containing a complete copy of the cDNA corresponding to Sindbis 26S RNA is described in the legend to Fig. 1 (56) . Wild-type vaccinia virus plaques gave no signal, whereas a large number of strongly hybridizing plaques were obvious in the VV3S population. Individual positive plaques were recovered by punching out the corresponding regions from a replica nitrocellulose filter and subjected to at least two cycles of plaque purification until each isolate scored as 100% positive in the plaque hybridization assay. One of the putative positive vaccinia-Sindbis recombinants, VV3S-7, was used for further experiments.
Genomic structure of VV3S-7. The structure of the genome of vaccina recombinant VV3S-7 was probed by restriction mapping and blot analysis (49) . At the bottom of Fig. 2 Transcription of Sindbis sequences. BSC-40 cells were infected with vaccinia recombinant VV3S-7 in the presence of cycloheximide (100 ,ug/ml) to amplify early mRNA sequences. At 5 h postinfection, the cytoplasmic RNA was extracted and purified, and the poly(A)+ fraction was obtained by oligo(dT)-cellulose chromatography. This RNA was fractionated by electrophoresis on denaturing formaldehyde gels, transferred to nitrocellulose, and subjected to Northern blot analyses with nick-translated pVV3S as a probe. A 4.7-kb RNA which was transcribed from the vaccinia recombinant hybridized to the probe (Fig. 3 To determine the 5' end of the VV3S-7 Sindbis-specific transcripts nuclease S1 mapping procedures were used (Fig.  4) derived exclusively from the early 7.5K transcription start (Fig. 4) (Fig. 5) . In Sindbis-infected cells (Fig. 5, right side) (Fig. 5, left  side) . In cells infected with the vaccinia recombinant VV3S-7, Sindbis proteins PE2, El, E2, and C were present (Fig. 5, center lanes) . The Sindbis proteins from VV3S-7-infected cells comigrate with authentic Sindbis proteins, which suggests that they have been correctly cleaved and processed. In an attempt to quantitate the amount of Sindbis-specific proteins synthesized in VV3S-7-infected cells, radioactive extracts from cells infected with equivalent multiplicities of VV3S-7 or Sindbis were immunoprecipitated, and the radioactivity was assayed; after 4 A second series of experiments which involved pulselabeling is shown in Fig. 6b . Three important features of VV3S-7 expression of Sindbis proteins are seen. First, the Sindbis proteins are synthesized throughout the infection cycle. Second, there appear to be two peaks of expression, one at 2 h and one later in infection. This may be due to the shift from early to late transcription by the 7.5K promoter, but it could involve posttranscriptional processes as well. Finally, it can be seen that during a pulse no E2 is produced, but rather the precursor to E2 is present. The pulse-chase studies shown in Fig. 6c show that PE2 can be chased into - 256   FIG. 4 . Si analysis. RNA was isolated at four hours postinfection from either wild-type vaccinia (VV wt), VV3S-7, or Sindbis (SV) virus-infected cell monolayers as indicated. Equal proportions of these samples were annealed with an excess of a 5' end-labeled probe derived from pVV3S, digested with Si, and protected fragments were denatured and separated on 4% acrylamide-urea sequencing gels. For the Sindbis-infected RNA sample, 5% (right lane) or 10% (left lane) of the protected material was loaded. The probe was the 1530 nucleotide HindIII-NcoI fragment of pVV3S, 5' end-labeled at the NcoI site which is 445 nucleotides 3' to the start of the 26S cDNA insert. Two protected fragments were found in Sindbis virus-infected cells corresponding to 26S RNA (445 nucleotides) and 49S RNA (454 nucleotides). Protected fragments in VV3S-7-infected cells corrsponded to the early 7.5K promoter start (504 nucleotides) and, in permissive cells, to the late 7.5K promoter start (-560 nucleotides, seen only in the VV3S-7-infected BSC-40 and BHK lanes). The sizes of the end-labeled DNA markers (M) are indicated.
E2. It is interesting to note that PE2-to-E2 processing kinetics appear to occur at the same rate in Sindbis-and VV3S-7-infected cells. It also appears (Fig. 6c ) that all three Sindbis proteins turn over in these experiments and that these proteins are more labile in the VV3S-7-infected cells than in Sindbis-infected cells. Note also that the 108K polyprotein is present in small amounts in Sindbis-infected cells (where it turns over rapidly) but is not seen in VV3S-7-infected cells.
We also examined several other cell lines, both permissive and nonpermissive for vaccinia replication, for the production of Sindbis proteins after infection by VV3S-7, and some of the results are shown in Fig. 6d . CHO, MDBK, BHK, and chicken embryo fibroblast cells infected with VV3S-7 all produced the same series of Sindbis proteins as infected BSC-40 cells. Thus, even in cell lines nonpermissive for vaccinia growth (CHO and MDBK cells), the expression of the Sindbis-specific transcripts and protein products is efficient, and proteolytic processing of the polyprotein precursor occurs.
Posttranslational modifications of Sindbis proteins. Sindbis El and E2 proteins are glycosylated membrane proteins. The PE2, El, and E2 proteins found after infection with Sindbis or vaccinia VV3S-7 comigrated in one-dimensional polyacrylamide gels, which is suggestive evidence for similar states of glycosylation. Two additional experiments which support this observation were conducted. First, the effect of tunicamycin, a drug which inhibits N glycosylation, on Sindbis and VV3S-7 protein expression was assayed (Fig. 7) . Sindbis or VV3S-7 proteins that were synthesized in either the presence or the absence of the drug comigrated. The nonglycosylated forms of PE2 and El, synthesized in the presence of the drug, comigrated, which implies that the polypeptide backbones of the Sindbis proteins and the VV3S-7 proteins are identical. Thus, the fact that the glycosylated forms of Sindbis and VV3S-7 proteins also comigrate implies that they are glycosylated in a similar, if not identical, manner. Second, the VV3S-7-derived PE2, El, and E2 proteins were shown to be specifically labeled (as opposed to the capsid protein) with the radioactive sugar [3H]glucosamine (Fig. 7) .
Transport of Sindbis virus proteins. During a Sindbis virus infection, the virus envelope proteins are core glycosylated during insertion into the endoplasmic reticulum, and the core oligosaccharides are modified during the translocation of the envelope proteins from the site of their synthesis to the cell surface. The VV3S-7-derived Sindbis proteins appear to be modified in the same way as are authentic Sindbis proteins, which implies that these proteins are also being transported to the cell surface. To assay this directly we used a radioimmune assay in which anti-Sindbis antibodies were adsorbed to the surface of infected cells, followed by incubation with 1251I-labeled protein A from Staphylococcus aureus. infected cells (Table 1) , it would appear that these proteins are present at 12% the amount found in Sindbis-infected cells.
In a second experiment, the Sindbis proteins present on the surface of BHK cells infected by vaccinia VV3S-7 were visualized by indirect immunofluorescence. At 8 h postinfection, the cells were fixed and incubated with either El or E2 monospecific antibodies (Fig. 8) . Although wild-type vaccinia-infected cells showed a weak and diffuse pattern of immunofluorescent staining, both El and E2 (or PE2) could be specifically detected in the surface of VV3S-7-infected cells. The (20, 29, 59) , has been postulated to be catalyzed by a Golgi protease during transit to the plasma membrane (9, 37) . The expression experiments reported here as well as other expression experiments using Semliki Forest virus (19) show that this processing can occur in the absence of virus budding.
Previous attempts to express cloned copies of alphavirus 26S RNA have used DNA copies under the control of simian virus 40 promoters microinjected into nuclei (10, 22, 23 
